Therapeutic Solutions International Inc (TSOI)
0.0006
0.00 (0.00%)
USD |
OTCM |
Apr 24, 14:36
Therapeutic Solutions International Gross Profit Margin (Quarterly): 55.73% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 55.73% |
| September 30, 2023 | 72.59% |
| June 30, 2023 | 59.33% |
| March 31, 2023 | 63.39% |
| December 31, 2022 | -436.2% |
| September 30, 2022 | 88.21% |
| June 30, 2022 | 77.52% |
| March 31, 2022 | 81.23% |
| December 31, 2021 | 66.15% |
| September 30, 2021 | 78.30% |
| June 30, 2021 | 82.57% |
| March 31, 2021 | 47.39% |
| December 31, 2020 | 76.88% |
| September 30, 2020 | 76.00% |
| June 30, 2020 | 82.43% |
| March 31, 2020 | 82.12% |
| December 31, 2019 | 88.47% |
| September 30, 2019 | 88.67% |
| June 30, 2019 | 88.40% |
| March 31, 2019 | 94.07% |
| December 31, 2018 | |
| September 30, 2018 | 83.04% |
| June 30, 2018 | 89.79% |
| March 31, 2018 | 82.50% |
| December 31, 2017 | 77.69% |
| Date | Value |
|---|---|
| September 30, 2017 | 69.68% |
| June 30, 2017 | 69.53% |
| March 31, 2017 | 63.87% |
| December 31, 2016 | 64.67% |
| September 30, 2016 | 70.17% |
| June 30, 2016 | 70.75% |
| March 31, 2016 | 73.58% |
| December 31, 2015 | -151.2% |
| September 30, 2015 | 48.92% |
| June 30, 2015 | 76.90% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | 96.66% |
| December 31, 2012 | 97.17% |
| September 30, 2012 | 97.15% |
| June 30, 2012 | 97.71% |
| March 31, 2012 | 97.72% |
| December 31, 2011 | 95.27% |
| September 30, 2011 | 97.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-436.2%
Minimum
Dec 2022
88.67%
Maximum
Sep 2019
48.38%
Average
77.52%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -163.6% |
| Return on Assets | -62.32% |
| Return on Invested Capital | -98.21% |
| Profit Margin (Quarterly) | -1.79K% |
| Operating Margin (Quarterly) | -2.34K% |
| Return on Net Operating Assets | -63.52% |